A multifunctional nanoparticle for efferocytosis and pro-resolving-mediated endometriosis therapy
article
OA: closed
CC0
⤵ 10 in-corpus citations
AI-generated summary
Researchers developed a multifunctional nanoparticle to enhance efferocytosis and deliver pro-resolving mediators for treating endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is an inflammation-dependent disorder characterized by the abnormal growth of endometrium-like lesions. In recent years, there is a great deal of interest in the development of anti-inflammatory therapy. Herein, an acid-sensitive calcium carbonate nanoparticle (CaNP) incorporated BML-111 (BML@CaNP) was prepared. BML@CaNP acted as a Ca2+ nanomodulator for efferocytosis (macrophages engulf apoptotic cells). Specifically, BML@CaNP induced the apoptosis of endometriotic stromal cells and enhanced the efferocytosis of macrophages. In addition, the particle can also deliver BML to the ectopic lesion for resolving the inflammatory response. In vivo BML@CaNP effectively suppressed lesion growth in endometriosis mice model, which could be attributed to the enhancing efferocytosis of cells and the lower levels of inflammatory factors in peritoneal fluid. In addition, these nanoparticles did not show side effects. In all, we provide a new anti-inflammatory strategy by both enhancing efferocytosis and resolving inflammation for the treatment of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- Curcumin-loaded nanofibers for targeting endometriosis in the peritoneum of a mouse model via openalex
- Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis via openalex
- Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Estrogen Receptor β Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis via openalex
- Evaluation of PLGA containing anti -CTLA4 inhibited endometriosis progression by regulating CD4 + CD25 + Treg cells in peritoneal fluid of mouse endometriosis model via openalex
- Lipoxin A4 Suppresses Estrogen-Induced Epithelial-Mesenchymal Transition via ALXR-Dependent Manner in Endometriosis via openalex
- Lipoxin A4 Suppresses IL-1β-Induced Cyclooxygenase-2 Expression Through Inhibition of p38 MAPk Activation in Endometriosis via openalex
- Lipoxin <scp>A</scp><sub>4</sub> suppresses the development of endometriosis in an <scp>ALX</scp> receptor‐dependent manner via the p38 <scp>MAPK</scp> pathway via openalex
- Macrophage Immune Memory Controls Endometriosis in Mice and Humans via openalex
- Mitochondria and oxidative stress in ovarian endometriosis via openalex
- The endometrial immune environment of women with endometriosis via openalex
- The role of Lipoxin A4 in endometrial biology and endometriosis via openalex
- W2998111538 via openalex
- W3080704705 via openalex
- W3094730270 via openalex
- W3114628698 via openalex
- W3123286810 via openalex
- W3126917016 via openalex
- W3129581908 via openalex
- W3135689015 via openalex
- W3161127759 via openalex
- W3164174648 via openalex
- W3165294846 via openalex
- W3176747598 via openalex
- W3212362994 via openalex
- W4200564056 via openalex
- W4234160457 via openalex
- W4281721773 via openalex
- W1601517895 via openalex
- W2003027438 via openalex
- W2015677100 via openalex
- W2028906750 via openalex
- W2031325281 via openalex
- W2156416313 via openalex
- W2757350733 via openalex
- W2759443181 via openalex
- W2884952568 via openalex
- W2918019780 via openalex
- W2945926178 via openalex
- W2997768937 via openalex
Cited by (10)
- Regulated cell death in endometrial diseases: from molecular mechanisms to targeted therapies 2025
- Endometriosis and autoimmunity 2025
- A novel fertility-sparing nanocomposite for endometriosis treatment via oxidative stress and inflammation alleviation 2025
- Cell membrane camouflaged and ROS responsive nanosomes for targeted endometriosis therapy via reversing inflammatory, low-autophagy, and immunotolerant microenvironment 2024
- Medical management of endometriosis 2024
- Emerging bioengineering breakthroughs in precision diagnosis and therapy for endometriosis and adenomyosis 2024
- Emerging strategies for the treatment of endometriosis 2024
- Advancing Precision Nutrition in Endometriosis Care: The Role of Nutrigenomics and Nutrigenetics 2024
- The role and potential treatment of macrophages in patients with infertility and endometriosis 2024
- LGALS2 and EGR1: markers of endometriosis for predictive, preventive and personalized medicine 2023
Source provenance
- europepmc
- last seen: 2026-06-19T06:14:56.452680+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-19T06:14:29.062243+00:00
License: CC0
· commercial use OK